General practices to receive response on COVID EOIs imminently Hundreds of general practices will be involved in the initial vaccine rollout, with numbers ramping up as more doses become available.
What the TGA means by ‘case-by-case’ basis for over 65s The approval of the Oxford University/AstraZeneca vaccine has raised some unanswered questions, but RACGP President Dr Karen Price says GPs are still well equipped to handle the rollout.
New considerations for GPs ahead of vaccine rollout Recent studies suggest some coronavirus variants may reduce vaccine efficacy rates. newsGP explores what this could mean for GPs.
What’s the difference between mutations, variants and strains? Two virologists provide a guide to deciphering the latest set of COVID terminology.
How a ‘lower-efficacy’ vaccine could take us to herd immunity Some have claimed highly effective mRNA vaccines are the only available candidates that would allow Australia to reach herd immunity against COVID-19. But what if there’s another way?
Will COVID vaccines need to be updated to beat new variants? Vaccine makers are gearing up for a new challenge: providing coverage against the multiple variants replacing the original coronavirus strain.
Four things about mRNA vaccines researchers still want to find out At the top of the list is discovering a way to make them more stable at higher temperatures.
Study identifies four main comorbidities associated with COVID deaths Coronavirus patients with cancer, chronic kidney disease, diabetes or hypertension were found to be most at risk of death.
‘Professional attendance’ a sticking point in COVID vaccine rollout More than 5000 general practices have put their hand up to take part in the nationwide vaccination program, but questions over MBS rebate requirements could stall momentum.
Vaccine’s reduced efficacy against COVID variant ‘worrying’ South Africa has paused its rollout of the Oxford University/AstraZeneca coronavirus vaccine. What does this mean for Australia?